6.12 (-%)
As of Nov 22, 2024
Source:
We are a clinical-stage biotechnology company focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with significant unmet medical needs. We design and develop inhaled therapeutic products based on our proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Country | United States |
Headquarters | bedford, massachusetts |
Phone Number | (781) 357-2333 |
Industry | manufacturing |
CEO | Teofilo Raad |
Website | www.pulmatrix.com |